glutathione and ovarian cancer

glutathione and ovarian cancer Role of SLC7A11/xCT in glutathione in ovarian cancer a

Name: glutathione and ovarian cancer Role of SLC7A11/xCT in glutathione in ovarian cancer a
Brand: psychiatrist-in-kuwait.com
SKU: 42074164502
Price: 20.52 USD
Availability: InStock
Rating: 4.2241 (14 reviews)

glutathione in ovarian cancer a double edged sword Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Treatment Oxidative cell death in cancer: Glutathione: Lights and Shadows in Cancer Patients PMC Glutathione as a Prognostic Biomarker and a Potential Therapeutic Target for Ovarian Cancer Chemotherapy Resistance of Ovarian Cancer Encyclopedia MDPI Frontiers Unveiling drug resistance pathways in high grade serous ovarian cancer(HGSOC): recent advances and future perspectives

SKU: 42074164502 · From psychiatrist-in-kuwait.com

4.2

USD20.52 USD51.52

Pay in 4 interest-free payments of $5.13 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

doi: 10.1016/S0140-6736(14)60649-8 5 MachicadoJDYadavD

Halpern, K

Bin P, Huang R, Zhou X

10.5772/intechopen.90365 91 KumarS.PrasadM.RaoR

N6-methyladenosine (m 6 A) demethylase FTO is significantly upregulated in MPP + -stimulated SK-N-SH cells, which suppresses YTH domain family protein 2 (YTHDF2) expression, promotes m 6 A demethylation of BRCA1-associated protein 1 (BAP1) and enhances BAP1 expression, upregulates p53 expression, and inhibits SLC7A11 transcription, thereby increasing MDA, Fe 2+ , and 4-HNE levels and triggering neuronal ferroptosis